{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T08:14:02Z","timestamp":1776845642332,"version":"3.51.2"},"reference-count":64,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Anaesthesiology"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.bpa.2015.03.007","type":"journal-article","created":{"date-parts":[[2015,4,5]],"date-time":"2015-04-05T17:11:37Z","timestamp":1428253897000},"page":"257-270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Pharmacologic approaches to weaning from cardiopulmonary bypass and extracorporeal membrane oxygenation"],"prefix":"10.1016","volume":"29","author":[{"given":"Wilson W.","family":"Cui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James G.","family":"Ramsay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpa.2015.03.007_bib1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1053\/j.jvca.2008.08.007","article-title":"The inflammatory response to cardiopulmonary bypass: part 1\u2013mechanisms of pathogenesis","volume":"23","author":"Warren","year":"2009","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.bpa.2015.03.007_bib2","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4103\/0971-9784.97977","article-title":"Clinical review: management of weaning from cardiopulmonary bypass after cardiac surgery","volume":"15","author":"Licker","year":"2012","journal-title":"Ann Card Anaesth"},{"key":"10.1016\/j.bpa.2015.03.007_bib3","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1056\/NEJMoa0802395","article-title":"A\u00a0comparison of aprotinin and lysine analogues in high-risk cardiac surgery","volume":"358","author":"Fergusson","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpa.2015.03.007_bib4","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.athoracsur.2010.11.078","article-title":"2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular anesthesiologists blood conservation clinical practice guidelines","volume":"91","author":"Ferraris","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.bpa.2015.03.007_bib5","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1067\/mtc.2002.126038","article-title":"Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII","volume":"124","author":"Bui","year":"2002","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.bpa.2015.03.007_bib6","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/cc3024","article-title":"Bench-to-bedside review: inotropic drug therapy after adult cardiac surgery\u2013a systemic literature review","volume":"3","author":"Gillies","year":"2005","journal-title":"Crit Care"},{"key":"10.1016\/j.bpa.2015.03.007_bib7","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0022-5223(98)70049-2","article-title":"Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent","volume":"116","author":"Argenziano","year":"1998","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.bpa.2015.03.007_bib8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1540-8191.2000.tb00470.x","article-title":"Low systemic vascular resistance after cardiopulmonary bypass: incidence, etiology, and clinical importance","volume":"15","author":"Carrel","year":"2000","journal-title":"J\u00a0Card Surg"},{"key":"10.1016\/j.bpa.2015.03.007_bib9","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1161\/CIRCULATIONAHA.108.814533","article-title":"Early on-cardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome","volume":"120","author":"Levin","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.bpa.2015.03.007_bib10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0022-5223(19)39993-3","article-title":"Antidiuretic hormone levels during cardiopulmonary bypass","volume":"73","author":"Philbin","year":"1977","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.bpa.2015.03.007_bib11","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJMra002709","article-title":"The pathogenesis of vasodilatory shock","volume":"345","author":"Landry","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpa.2015.03.007_bib12","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0003-4975(02)04408-9","article-title":"A\u00a0double-blind randomized trial: prophylactic vasopressin reduces hypotension after cardiopulmonary bypass","volume":"75","author":"Morales","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.bpa.2015.03.007_bib13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1053\/j.jvca.2009.08.001","article-title":"Prophylactic vasopressin in patients receiving the angiotensin-converting enzyme inhibitor ramipril undergoing coronary artery bypass graft surgery","volume":"24","author":"Hasija","year":"2010","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.bpa.2015.03.007_bib14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1749-8090-5-17","article-title":"Perioperative infusion of low- dose of vasopressin for prevention and management of vasodilatory vasoplegic syndrome in patients undergoing coronary artery bypass grafting-a double-blind randomized study","volume":"5","author":"Papadopoulos","year":"2010","journal-title":"J\u00a0Cardiothorac Surg"},{"key":"10.1016\/j.bpa.2015.03.007_bib15","first-page":"286","article-title":"A\u00a0prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement","volume":"96:II","author":"Argenziano","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.bpa.2015.03.007_bib16","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1161\/01.CIR.0000066692.71008.BB","article-title":"Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study","volume":"107","author":"D\u00fcnser","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.bpa.2015.03.007_bib17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1034\/j.1399-6576.1999.430307.x","article-title":"The role of nitric oxide in sepsis \u2013 an overview","volume":"43","author":"Kirkeboen1","year":"1999","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.bpa.2015.03.007_bib18","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/S0022-5223(02)73284-4","article-title":"Methylene blue: the drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass","volume":"125","author":"Leyh","year":"2003","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.bpa.2015.03.007_bib19","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0003-4975(03)01510-8","article-title":"Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery","volume":"77","author":"Levin","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.bpa.2015.03.007_bib20","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.athoracsur.2004.10.038","article-title":"Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery","volume":"79","author":"Ozal","year":"2005","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.bpa.2015.03.007_bib21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1213\/01.ane.0000221261.25310.fe","article-title":"The hemodynamic effects of methylene blue when administered at the onset of cardiopulmonary bypass","volume":"103","author":"Maslow","year":"2006","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bpa.2015.03.007_bib22","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1053\/j.jvca.2013.02.026","article-title":"Methylene blue is associated with poor outcomes in vasoplegic shock","volume":"27","author":"Weiner","year":"2013","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.bpa.2015.03.007_bib23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1055\/s-2007-1013790","article-title":"The efficacy of amrinone or adrenaline on low cardiac output following cardiopulmonary bypass in patients with coronary artery disease undergoing preoperative beta-blockade","volume":"43","author":"G\u00fcnnicker","year":"1995","journal-title":"Thorac Cardiovasc Surg"},{"key":"10.1016\/j.bpa.2015.03.007_bib24","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/1053-0770(92)90095-O","article-title":"Dobutamine increases heart rate more than epinephrine in patients recovering from aortocoronary bypass surgery","volume":"6","author":"Butterworth","year":"1992","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.bpa.2015.03.007_bib25","first-page":"15","article-title":"Haemodynamic effects and comparison of enoximone, dobutamine and dopamine following mitral valve surgery","volume":"8","author":"Tarr","year":"1993","journal-title":"Eur J Anaesthesiol Suppl"},{"key":"10.1016\/j.bpa.2015.03.007_bib26","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1097\/00000542-199911000-00024","article-title":"Effects of dobutamine on hemodynamics and left ventricular performance after cardiopulmonary bypass in cardiac surgical patients","volume":"91","author":"Romson","year":"1999","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bpa.2015.03.007_bib27","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1053\/jcan.2001.23274","article-title":"Comparison of the hemodynamic effects of milrinone with dobutamine in patients after cardiac surgery","volume":"15","author":"Feneck","year":"2001","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.bpa.2015.03.007_bib28","first-page":"237","article-title":"Comparison of the effects of dobutamine and milrinone on hemodynamic parameters and oxygen supply in patients undergoing cardiac surgery with low cardiac output after anesthetic induction","volume":"60","author":"Carmona","year":"2010","journal-title":"Rev Bras Anestesiol"},{"key":"10.1016\/j.bpa.2015.03.007_bib29","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1097\/00003246-200007000-00027","article-title":"Differential effects of dopamine, dopexamine, and dobutamine on jejunal mucosal perfusion early after cardiac surgery","volume":"28","author":"Thor\u00e9n","year":"2000","journal-title":"Crit Care Med"},{"key":"10.1016\/j.bpa.2015.03.007_bib30","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s10741-011-9235-5","article-title":"Pharmacological therapies for the prevention of acute kidney injury following cardiac surgery: a systematic review","volume":"16","author":"Patel","year":"2011","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.bpa.2015.03.007_bib31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF01683138","article-title":"Haemodynamic effects of dopamine, epinephrine and orciprenaline (Alupent) in patients early after cardiac surgery","volume":"4","author":"Gattiker","year":"1978","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.bpa.2015.03.007_bib32","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0003-4975(10)63198-0","article-title":"Comparison of dopamine and dobutamine following coronary artery bypass grafting","volume":"33","author":"Salomon","year":"1982","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.bpa.2015.03.007_bib33","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1007\/s001340050439","article-title":"Postcardiac surgery low cardiac output syndrome: dopexamine or dopamine?","volume":"23","author":"Rosseel","year":"1997","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.bpa.2015.03.007_bib34","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/clc.4960090604","article-title":"Comparison of dopamine and dobutamine in patients requiring postoperative circulatory support","volume":"9","author":"DiSesa","year":"1986","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.bpa.2015.03.007_bib35","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1097\/00000539-200106000-00004","article-title":"Inhibition of phosphodiesterase type III before aortic cross-clamping preserves intramyocardial cyclic adenosine monophosphate during cardiopulmonary bypass","volume":"92","author":"Janelle","year":"2001","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bpa.2015.03.007_bib36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1053-0770(97)90250-0","article-title":"A\u00a0placebo-controlled trial verifying the efficacy of milrinone in weaning high-risk patients from cardiopulmonary bypass","volume":"11","author":"Doolan","year":"1997","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.bpa.2015.03.007_bib37","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1093\/bja\/81.5.782","article-title":"A\u00a0single dose of milrinone facilitates separation from cardiopulmonary bypass in patients with pre-existing left ventricular dysfunction","volume":"81","author":"Lobato","year":"1998","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bpa.2015.03.007_bib38","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1213\/00000539-200201000-00005","article-title":"The efficacy of preemptive Milrinone or amrinone therapy in patients undergoing coronary artery bypass grafting","volume":"94","author":"Kikura","year":"2002","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bpa.2015.03.007_bib39","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1161\/CIRCULATIONAHA.108.790162","article-title":"Milrinone use is associated with postoperative atrial fibrillation after cardiac surgery","volume":"118","author":"Fleming","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.bpa.2015.03.007_bib40","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijcard.2011.07.022","article-title":"Levosimendan: molecular mechanisms and clinical implications: consensus of experts on the mechanisms of action of levosimendan","volume":"159","author":"Papp","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.bpa.2015.03.007_bib41","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1053\/j.jvca.2013.03.027","article-title":"Effect of levosimendan on survival and adverse events after cardiac surgery: a meta-analysis","volume":"27","author":"Harrison","year":"2013","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.bpa.2015.03.007_bib42","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1097\/CCM.0b013e3182227b97","article-title":"Levosimendan reduces heart failure after cardiac surgery: a prospective, randomized, placebo-controlled trial","volume":"39","author":"Lahtinen","year":"2011","journal-title":"Crit Care Med"},{"key":"10.1016\/j.bpa.2015.03.007_bib43","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.athoracsur.2008.10.029","article-title":"Levosimendan facilitates weaning from cardiopulmonary bypass in patients undergoing coronary artery bypass grafting with impaired left ventricular function","volume":"87","author":"Eriksson","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.bpa.2015.03.007_bib44","first-page":"125","article-title":"Preoperative levosimendan decreases mortality and the development of low cardiac output in high-risk patients with severe left ventricular dysfunction undergoing coronary artery bypass grafting with cardiopulmonary bypass","volume":"17","author":"Levin","year":"2012","journal-title":"Exp Clin Cardiol"},{"key":"10.1016\/j.bpa.2015.03.007_bib45","first-page":"389","article-title":"Hemodynamic effects of levosimendan following cardiac surgery","volume":"52","author":"Alvarez","year":"2005","journal-title":"Rev Esp Anestesiol Reanim"},{"key":"10.1016\/j.bpa.2015.03.007_bib46","first-page":"338","article-title":"[Hemodynamic effects of levosimendan compared with dobutamine in patients with low cardiac output after cardiac surgery","volume":"59","author":"Alvarez","year":"2006","journal-title":"Rev Espa\u00f1ola Cardiol"},{"key":"10.1016\/j.bpa.2015.03.007_bib47","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1053\/j.jvca.2006.02.012","article-title":"Levosimendan or milrinone in the type 2 diabetic patient with low ejection fraction undergoing elective coronary artery surgery","volume":"20","author":"Al-Shawaf","year":"2006","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.bpa.2015.03.007_bib48","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1213\/01.ane.0000256863.92050.d3","article-title":"The effects of levosimendan in cardiac surgery patients with poor left ventricular function","volume":"104","author":"De Hert","year":"2007","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bpa.2015.03.007_bib49","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1016\/j.jtcvs.2014.07.076","article-title":"Systolic anterior motion of the mitral valve: a 30-year perspective","volume":"148","author":"Loulmet","year":"2014","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.bpa.2015.03.007_bib50","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.jtcvs.2012.01.063","article-title":"Management of systolic anterior motion after mitral valve repair: an algorithm","volume":"143","author":"Varghese","year":"2012","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.bpa.2015.03.007_bib51","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1016\/S0735-1097(99)00464-7","article-title":"Echocardiographic predictors of left ventricular outflow tract obstruction and systolic anterior motion of the mitral valve after mitral valve reconstruction for myxomatous valve disease","volume":"34","author":"Maslow","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.bpa.2015.03.007_bib52","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.amjcard.2011.08.040","article-title":"Usefulness of two-dimensional echocardiographic parameters of the left side of the heart to predict right ventricular failure after left ventricular assist device implantation","volume":"109","author":"Kato","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.bpa.2015.03.007_bib53","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.jtcvs.2009.11.020","article-title":"Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes","volume":"139","author":"Kormos","year":"2010","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.bpa.2015.03.007_bib54","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1056\/NEJMoa0909938","article-title":"Advanced heart failure treated with continuous-flow left ventricular assist device","volume":"361","author":"Slaughter","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpa.2015.03.007_bib55","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/ejcts\/ezs104","article-title":"Are right ventricular risk scores useful?","volume":"42","author":"Pettinari","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.bpa.2015.03.007_bib56","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/ACO.0b013e32835b8be2","article-title":"Perioperative right ventricular dysfunction","volume":"26","author":"Denault","year":"2013","journal-title":"Curr Opin Anaesthesiol"},{"key":"10.1016\/j.bpa.2015.03.007_bib57","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1161\/01.CIR.83.6.2038","article-title":"Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction","volume":"83","author":"Frostell","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.bpa.2015.03.007_bib58","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.athoracsur.2006.06.081","article-title":"Clinical indication for use and outcomes after inhaled nitric oxide therapy","volume":"82","author":"George","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.bpa.2015.03.007_bib59","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A\u00a0comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension","volume":"334","author":"Barst","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpa.2015.03.007_bib60","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2459\/01.JCM.0000203850.97890.fe","article-title":"Treatment of pulmonary hypertension in patients undergoing cardiac surgery with cardiopulmonary bypass: a randomized, prospective, double-blind study","volume":"7","author":"Fattouch","year":"2006","journal-title":"J\u00a0Cardiovasc Med Hagerst"},{"key":"10.1016\/j.bpa.2015.03.007_bib61","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.jtcvs.2009.04.063","article-title":"A\u00a0prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients","volume":"138","author":"Khan","year":"2009","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.bpa.2015.03.007_bib62","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/ACO.0b013e3283346c51","article-title":"Intraoperative management of pulmonary hypertension and associated right heart failure","volume":"23","author":"Gordon","year":"2010","journal-title":"Curr Opin Anaesthesiol"},{"key":"10.1016\/j.bpa.2015.03.007_bib63","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s12325-009-0019-4","article-title":"Comparison of inhaled and intravenous milrinone in patients with pulmonary hypertension undergoing mitral valve surgery","volume":"26","author":"Wang","year":"2009","journal-title":"Adv Ther"},{"key":"10.1016\/j.bpa.2015.03.007_bib64","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.ejcts.2006.02.032","article-title":"Comparative hemodynamic effects of vasopressin and norepinephrine after milrinone-induced hypotension in off-pump coronary artery bypass surgical patients","volume":"29","author":"Jeon","year":"2006","journal-title":"Eur J Cardiothorac Surg"}],"container-title":["Best Practice & Research Clinical Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521689615000191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521689615000191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T12:00:18Z","timestamp":1776427218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521689615000191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":64,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S1521689615000191"],"URL":"https:\/\/doi.org\/10.1016\/j.bpa.2015.03.007","relation":{},"ISSN":["1753-3740"],"issn-type":[{"value":"1753-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacologic approaches to weaning from cardiopulmonary bypass and extracorporeal membrane oxygenation","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Anaesthesiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpa.2015.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}